Inventor
TREIBER HANS-JOERG
DE29 patents
⚠️ This page may combine multiple inventors who share the name “TREIBER HANS-JOERG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BASF AG
14 patentsUS6630493B1Oct 7, 2003
Heterocyclically substituted amides, their preparation and use
BASF AG35 citations92
US6251917B1Jun 26, 2001
Benzamidoaldehydes and their use as cysteine protease inhibitors
BASF AG31 citations92
US6214822B1Apr 10, 2001
Substituted aza and diazacycloheptane and cyclooctane compounds and their use
BASF AG21 citations92
US6103720AAug 15, 2000
Ketobenzamides as calpain inhibitors
BASF AG45 citations92
US6352981B1Mar 5, 2002
Substituted AZA- and diazacycloheptane and -cyclooctane
BASF AG14 citations84
US6172072B1Jan 9, 2001
Heterocyclically substituted benzamides and their use in fighting diseases
BASF AG12 citations74
US6121265ASep 19, 2000
Heterocyclic substituted imidazoloquinoxalinones, their preparation and their use
BASF AG5 citations63
US5371088ADec 6, 1994
1-aryl-4-piperazinylcyclohexanecarbonitriles, the preparation and use thereof
BASF AG3 citations62
US5342839AAug 30, 1994
2-hydroxy-3-phenoxy-propyl-substituted piperazines, their preparation and use
BASF AG2 citations62
US5538972AJul 23, 1996
Imidazoloquinoxalinones for the treatment of central nervous disorders
BASF AG0 citations52
US5049583ASep 17, 1991
Noremopamil, and its use for treating hypoxic conditions
BASF AG0 citations52
US5654310AAug 5, 1997
Triazolopyrimidones their preparation and use
BASF AG0 citations51
US5631261AMay 20, 1997
Triazoloquinazolines, their preparation and use
BASF AG0 citations51
US5612344AMar 18, 1997
Triazoloquinazolines for the treatment of central nervous disorders
BASF AG0 citations41
ABBOTT LAB
9 patentsUS6436925B1Aug 20, 2002
Substituted benzamides, their production and their use as cysteine protease inhibitors
ABBOTT LAB59 citations96
US6562827B1May 13, 2003
Heterocyclically substituted amides used as calpain inhibitors
ABBOTT LAB50 citations92
US6482832B1Nov 19, 2002
Heterocyclically substituted amides, their production and their use
ABBOTT LAB25 citations92
US6448254B1Sep 10, 2002
Substituted amides, their production and their use
ABBOTT LAB53 citations92
US6602867B1Aug 5, 2003
Triazole compounds with dopamine-D3-receptor affinity
ABBOTT LAB15 citations90
US6579892B1Jun 17, 2003
Triazole compounds with dopamine-D3-receptor affinity
ABBOTT LAB20 citations90
US6472392B1Oct 29, 2002
Triazole compounds and the use thereof as dopamine-D3 -ligands
ABBOTT LAB46 citations90
US6436949B1Aug 20, 2002
Heterocyclically substituted benzamides and their use
ABBOTT LAB15 citations84
US6583166B1Jun 24, 2003
Triazole compounds with dopamine-D3-receptor affinity
ABBOTT LAB7 citations71
ABBOTT GMBH & CO KG
5 patentsUS6753327B1Jun 22, 2004
Substituted amides, their preparation and use
ABBOTT GMBH & CO KG10 citations73
US7098214B1Aug 29, 2006
Dopamine D3 receptor ligands or antagonists for use in the treatment of renal function disorders
ABBOTT GMBH & CO KG5 citations71
US7956093B2Jun 7, 2011
Substituted amides, their preparation and use
ABBOTT GMBH & CO KG4 citations62
US7465744B2Dec 16, 2008
Triazole compounds and the therapeutic use thereof
ABBOTT GMBH & CO KG2 citations60
US7276500B2Oct 2, 2007
Substituted amides, their preparation and use
ABBOTT GMBH & CO KG1 citations52